Biblioteca Digital de VanguardiaAccess to antiretrovirals: effects of intellectual property protection
Developing countries have been, in most cases, sceptical about the implementation of intellectual property protection (IPP) with the premise that this policy will hurt the coverage of medicines because the price of the drugs will be substantially high. This claim has overlooked the long run effect o...
| Autores principales: | , |
|---|---|
| Formato: | info:eu-repo/semantics/article |
| Lenguaje: | Español |
| Publicado: |
Universidad del Pacífico
2009
|
| Acceso en línea: | https://revistas.up.edu.pe/index.php/apuntes/article/view/589 http://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/52920 |
| _version_ | 1782338339477651456 |
|---|---|
| author | Seinfeld, Janice Cai, Daolu |
| author_facet | Seinfeld, Janice Cai, Daolu |
| author_sort | Seinfeld, Janice |
| collection | Repositorio |
| description | Developing countries have been, in most cases, sceptical about the implementation of intellectual property protection (IPP) with the premise that this policy will hurt the coverage of medicines because the price of the drugs will be substantially high. This claim has overlooked the long run effect of IPP and has dismissed the other relevant policies to tackle the low drug coverage in poor countries. In this paper we measure the impact of IPP on Antiretroviral drugs coverage in 59 countries. According to our estimates, an increase in one unit in the IPP, measured by Park-Guinarte index, leads to an increase of 6% in antiretrovirals prices. However, the overall impact of IPP on coverage is positive; in fact, the marginal impact of a unit of increase in IPP on coverage is almost 14%. This is, most likely, due to the proper incentive framework provided by the IPP to create more and better drugs. Our findings also indicate that a key policy to complement the effect of IPP is an adequate level of health expenditure. Our estimates suggest that an increase of 1% in public expenditure on health as percentage of GDP increases by 3% to 4% the level of coverage of antiretrovirals. |
| format | info:eu-repo/semantics/article |
| id | clacso-CLACSO52920 |
| institution | CLACSO, Repositorio Digital |
| language | Español |
| publishDate | 2009 |
| publisher | Universidad del Pacífico |
| record_format | greenstone |
| spelling | clacso-CLACSO529202022-03-17T18:48:05Z Access to antiretrovirals: effects of intellectual property protection Acceso a antirretrovirales: efectos de la protección a la propiedad intelectual Seinfeld, Janice Cai, Daolu Developing countries have been, in most cases, sceptical about the implementation of intellectual property protection (IPP) with the premise that this policy will hurt the coverage of medicines because the price of the drugs will be substantially high. This claim has overlooked the long run effect of IPP and has dismissed the other relevant policies to tackle the low drug coverage in poor countries. In this paper we measure the impact of IPP on Antiretroviral drugs coverage in 59 countries. According to our estimates, an increase in one unit in the IPP, measured by Park-Guinarte index, leads to an increase of 6% in antiretrovirals prices. However, the overall impact of IPP on coverage is positive; in fact, the marginal impact of a unit of increase in IPP on coverage is almost 14%. This is, most likely, due to the proper incentive framework provided by the IPP to create more and better drugs. Our findings also indicate that a key policy to complement the effect of IPP is an adequate level of health expenditure. Our estimates suggest that an increase of 1% in public expenditure on health as percentage of GDP increases by 3% to 4% the level of coverage of antiretrovirals. Los países en desarrollo se han mostrado generalmente reticentes a implementar políticas de protección a la propiedad intelectual (PPI), bajo la premisa de que esta política dañará el acceso a medicamentos dado el incremento en los precios de los mismos. Esta afirmación, sin embargo, ignora los posibles efectos de largo plazo de la PPI e ignora otras políticas relevantes para mejorar el acceso a los medicamentos en los países pobres. En este trabajo se mide el impacto de la PPI en la cobertura de antirretrovirales para 59 países. De acuerdo con las estimaciones, un incremento de una unidad en el índice de PPI, medido por el índice de Park-Guinarte, conlleva un incremento de 6% en el precio de los antirretrovirales. Sin embargo, el impacto neto de la PPI sobre la cobertura es positivo; en efecto, el impacto marginal de incrementar un punto en el índice de Park-Guinarte sobre la cobertura de antirretrovirales es de 14%. Esto probablemente se deba a los incentivos que genera la protección a la propiedad intelectual para crear más y mejores medicamentos. Nuestros resultados también muestran que un instrumento clave de política para complementar el efecto de la PPI es un adecuado nivel de gasto en salud. Así, un incremento de 1% en el gasto público en salud como porcentaje del PBI, incrementa entre 3% y 4% el nivel de cobertura de los antirretrovirales. 2009-03-10 2022-03-17T18:48:05Z 2022-03-17T18:48:05Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion https://revistas.up.edu.pe/index.php/apuntes/article/view/589 10.21678/apuntes.65.589 http://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/52920 spa https://revistas.up.edu.pe/index.php/apuntes/article/view/589/591 Derechos de autor 2017 Apuntes http://creativecommons.org/licenses/by/4.0 application/pdf Universidad del Pacífico Apuntes. Social Sciences Journal; Apuntes 65; 5-30 Apuntes. Revista de ciencias sociales; Apuntes 65; 5-30 2223-1757 0252-1865 |
| spellingShingle | Seinfeld, Janice Cai, Daolu Access to antiretrovirals: effects of intellectual property protection |
| title | Access to antiretrovirals: effects of intellectual property protection |
| title_full | Access to antiretrovirals: effects of intellectual property protection |
| title_fullStr | Access to antiretrovirals: effects of intellectual property protection |
| title_full_unstemmed | Access to antiretrovirals: effects of intellectual property protection |
| title_short | Access to antiretrovirals: effects of intellectual property protection |
| title_sort | access to antiretrovirals: effects of intellectual property protection |
| url | https://revistas.up.edu.pe/index.php/apuntes/article/view/589 http://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/52920 |